Quick Answer
Amneal Pharmaceuticals, Inc. reported Total Revenue of $3.02 billion for the year ending 2025.
- Amneal Pharmaceuticals, Inc. showed an increase of +8.0% in Total Revenue from 2024 to 2025.
- This data is from Amneal Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $225.68 million | Q2 2017: $259.87 million | Q3 2017: $254.73 million | Q4 2017: $0.00 | Q4 2017: $293.37 million | Q1 2018: $0.00 | Q1 2018: $275.19 million | Q2 2018: $413.79 million | Q3 2018: $476.49 million | Q4 2018: $497.53 million | Q1 2019: $446.12 million | Q2 2019: $404.64 million | Q3 2019: $378.28 million | Q4 2019: $397.33 million | Q1 2020: $498.53 million | Q2 2020: $464.66 million | Q3 2020: $519.29 million | Q1 2021: $493.11 million | Q2 2021: $535.08 million | Q3 2021: $528.59 million | Q1 2022: $497.63 million | Q2 2022: $559.36 million | Q3 2022: $545.56 million | Q1 2023: $557.54 million | Q2 2023: $599.05 million | Q3 2023: $620.04 million | Q1 2024: $659.19 million | Q2 2024: $701.78 million | Q3 2024: $702.47 million | Q1 2025: $695.42 million | Q2 2025: $724.51 million | Q3 2025: $784.51 million.
- Over the full 10 years of available data (2016 to 2025), Amneal Pharmaceuticals, Inc.'s Total Revenue has grown by 196.5%.
- Historical annual values: Fiscal year 2025: $3.02 billion | Fiscal year 2024: $2.79 billion | Fiscal year 2023: $2.39 billion | Fiscal year 2022: $2.21 billion | Fiscal year 2021: $2.09 billion | Fiscal year 2020: $1.99 billion | Fiscal year 2019: $1.63 billion | Fiscal year 2018: $1.66 billion | Fiscal year 2017: $1.03 billion | Fiscal year 2016: $1.02 billion.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: